United States Of America to India: Bortezomib Import Trade Route
India has recorded 1 verified shipments of Bortezomib imported from United States Of America, representing a combined trade value of $22.4K USD. This corridor is served by 1 active United States Of America exporters, with an average shipment value of $22.4K USD. The leading United States Of America supplier is AGRACE PHARMA, which accounts for 100% of total import value with 1 shipments worth $22.4K USD. On the buying side, EXTROVIS PRIVATE LIMITED is the largest Indian importer with $22.4K USD in purchases. All data sourced from Indian Customs (DGFT) shipping bill of entry records. Values reported in FOB USD.
Route Intelligence Overview
The United States Of America to India Bortezomib corridor is one of India's established pharmaceutical import routes from United States Of America, with 1 shipments documented worth a combined $22.4K USD. The route is dominated by AGRACE PHARMA, which alone accounts for roughly 100% of all import value, reflecting the consolidated nature of United States Of America's bortezomib export sector.
Across 1 active United States Of America suppliers, the average shipment value stands at $22.4K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 78% of all shipments, consistent with bortezomib's non-urgent bulk-order profile.
Shipment activity peaks during January–March, with an average transit time of 34 days port-to-port. The route has recorded an annual growth rate of 13.5%, placing it at rank #19 among India's top bortezomib import origins globally.
On the Indian buyer side, key Indian importers include EXTROVIS PRIVATE LIMITED. EXTROVIS PRIVATE LIMITED is the single largest Indian importer with 1 shipments valued at $22.4K USD.
Route Characteristics
- Average transit34 days
- Peak seasonQ1
- Primary modeSea freight
- Top port of entryNA
Market Position
- Global rank#19
- Annual growth+13.5%
- Demand growth+13.7%
- Regulatory ease82/100
Top 10 Bortezomib Exporters from United States Of America to India
Showing top 10 of 1 United States Of America suppliers exporting Bortezomib to India, ranked by total trade value (USD)
| Rank | Supplier (United States Of America Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | AGRACE PHARMA Avg $22.4K per shipment | 1 | $22.4K | 100.0% |
This table shows the top 10 of 1 United States Of America companies exporting bortezomib to India, ranked by total trade value. The listed exporters are: AGRACE PHARMA. AGRACE PHARMA is the dominant supplier with 1 shipments worth $22.4K USD, giving it a 100% market share.
Top 10 Indian Bortezomib Importers from United States Of America
Showing top 10 of 1 known Indian buyers receiving Bortezomib shipments from United States Of America, ranked by import value
On the receiving end of this trade route, the leading Indian importers of United States Of America bortezomib include EXTROVIS PRIVATE LIMITED. The largest importer is EXTROVIS PRIVATE LIMITED, accounting for $22.4K USD across 1 shipments — representing 100% of all bortezomib imports from United States Of America on this route.
| Rank | Indian Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | EXTROVIS PRIVATE LIMITED | 1 | $22.4K | 100.0% |
Top 10 Bortezomib Formulations Imported from United States Of America
Showing top 10 of 1 product formulations shipped on the United States Of America to India Bortezomib route, ranked by trade value
India imports a wide range of bortezomib formulations from United States Of America, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — BORTEZOMIB FOR INJECTION 3.5 MG/VIAL (VELCADE)(PACK SIZE:1 VIAL) — accounts for $22.4K USD across 1 shipments. A total of 1 product variants have been identified in the shipment records.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | BORTEZOMIB FOR INJECTION 3.5 MG/VIAL (VELCADE)(PACK SIZE:1 VIAL) | 1 | $22.4K | 100.0% |
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Sea freight dominates at 78%, typical for bulk pharmaceutical shipments.
Top Indian Ports of Entry
NA handles the highest volume with 1 shipments. Transit time averages 34 days by sea.
Market Dynamics
India's bortezomib imports from United States Of America are driven primarily by a handful of large-scale United States Of America manufacturers. AGRACE PHARMA with 1 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 1 active exporters signals a competitive but concentrated market — Indian buyers benefit from United States Of America supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — AGRACE PHARMA — together account for 100% of total trade value on this route. The average shipment value of $22.4K USD reflects a mix of bulk commercial orders and smaller specialty shipments.
On the buying side, EXTROVIS PRIVATE LIMITED is the largest importer with 1 shipments worth $22.4K USD — representing 100% of all bortezomib imports from United States Of America on this route.
Route Statistics
- Trade Volume
- $22.4K
- Avg. Shipment
- $22.4K
- Suppliers
- 1
- Buyers
- 1
- Transit (Sea)
- ~34 days
- Annual Growth
- +13.5%
Related Analysis
Other Bortezomib Routes
Unlock the Full United States Of America to India Bortezomib Dataset
TransData Nexus provides verified shipment-level records, exporter contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 1 shipments on this route.
Frequently Asked Questions — United States Of America to India Bortezomib Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which United States Of America companies export Bortezomib to India?
The leading United States Of America exporters of Bortezomib to India are AGRACE PHARMA. AGRACE PHARMA holds the largest market share at approximately 100% of total trade value on this route.
Q What is the total value of Bortezomib imports from United States Of America to India?
India imports Bortezomib from United States Of America worth approximately $22.4K USD across 1 recorded shipments. The average value per shipment is $22.4K USD.
Q Which Indian ports receive Bortezomib from United States Of America?
The most active Indian port of entry is NA with 1 shipments. United States Of America exporters primarily use sea freight for this route, with 78% of shipments going by sea and 25% by air.
Q How long does shipping take from United States Of America to India for Bortezomib?
The average transit time for Bortezomib shipments from United States Of America to India is approximately 34 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during January–March.
Q Is the United States Of America to India Bortezomib import route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 13.5% with demand growth tracking at 13.7%. The route is ranked #19 among India's top Bortezomib import origins globally.
Q How many United States Of America suppliers are active on this Bortezomib import route?
There are currently 1 active United States Of America suppliers exporting Bortezomib to India. The market is moderately concentrated with AGRACE PHARMA accounting for 100% of total shipment value.
Q Who are the main Indian importers of Bortezomib from United States Of America?
The leading Indian importers of Bortezomib from United States Of America include EXTROVIS PRIVATE LIMITED. EXTROVIS PRIVATE LIMITED is the largest buyer with 1 shipments worth $22.4K USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to United States Of America export trade corridor identified from Indian Customs (DGFT) records for Bortezomib.
- 2.Supplier/Buyer Matching: 1 Indian exporters and 1 importers in United States Of America matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 1 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
1 Verified Shipments
1 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists